Literature DB >> 11897758

Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro.

Susanne Neumann1, Klaus Huse, Robert Semrau, Anno Diegeler, Rolf Gebhardt, Gayane Hrachia Buniatian, Gerhard H Scholz.   

Abstract

The renin-angiotensin-aldosterone-system appears to be involved in the development of cardiac fibrosis in rodents, characterized by nonepithelial cell proliferation and changes in the extracellular matrix. The aim of our study was to investigate the effect of high aldosterone concentrations on the proliferation of human cardiac interstitial cells in vitro. In addition, the effect of D-glucose as another risk factor for fibrosis, eg, in the diabetic heart, was investigated. Human cardiac myofibroblast cultures were established, and growth rates were measured by WST-1 assay in fetal calf serum-free Dulbecco's modified Eagle's medium (DMEM). Cells in culture showed a significant increase in number between 24 to 72 hours of cultivation under basal conditions (DMEM, 10% fetal calf serum). Aldosterone at high concentrations (10(-8) and 10(-7) mol/L) significantly (P<0.01) increased the proliferation of cultured cardiac myofibroblasts. Comparable effects were observed after incubation of the cells with high D-glucose concentrations (15 and 25 mmol/L, P<0.01). No additive growth stimulation was evident when the cells were incubated in medium containing both aldosterone and D -glucose. These results suggest a role for aldosterone and glucose in mediating the cardiac fibrosis through stimulation of myofibroblast growth in patients with dysregulated renin-angiotensin-aldosterone-system (especially hyperaldosteronism) and impaired glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897758     DOI: 10.1161/hy0302.105295

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Cyanidin-3-glucoside suppresses TNF-α-induced cell proliferation through the repression of Nox activator 1 in mouse vascular smooth muscle cells: involvement of the STAT3 signaling.

Authors:  Xiaoqin Luo; Shi Fang; Yunjun Xiao; Fenglin Song; Tangbin Zou; Min Wang; Min Xia; Wenhua Ling
Journal:  Mol Cell Biochem       Date:  2011-11-26       Impact factor: 3.396

3.  Iron-loaded cardiac myocytes stimulate cardiac myofibroblast DNA synthesis.

Authors:  Ying Liu; Douglas M Templeton
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix.

Authors:  Xiaoyi Zhang; James A Stewart; Ian D Kane; Erin P Massey; Dawn O Cashatt; Wayne E Carver
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-12       Impact factor: 2.416

5.  Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.

Authors:  Vaibhav B Patel; Sreedhar Bodiga; Ratnadeep Basu; Subhash K Das; Wang Wang; Zuocheng Wang; Jennifer Lo; Maria B Grant; JiuChang Zhong; Zamaneh Kassiri; Gavin Y Oudit
Journal:  Circ Res       Date:  2012-04-03       Impact factor: 17.367

6.  Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts.

Authors:  Patricia E Shamhart; Daniel J Luther; Ravi K Adapala; Jennifer E Bryant; Kyle A Petersen; J Gary Meszaros; Charles K Thodeti
Journal:  Can J Physiol Pharmacol       Date:  2014-01-31       Impact factor: 2.273

Review 7.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 8.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 9.  Heart disease in diabetic patients.

Authors:  Mihaela C Blendea; Samy I McFarlane; Esma R Isenovic; Gregory Gick; James R Sowers
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.